Model
Edge
4D Molecular Therapeutics
0001834021
Filing Type
4
Filing Date
6/25/2024
Updated
6/26/24, 3:07 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership